Drug Class
ALK inhibitor
Type
brand
Active Ingredient
brigatinib
📋Overview
Alunbrig is a medication primarily used in the management of certain types of lung cancer, specifically non-small cell lung cancer (NSCLC) that involves alterations in the ALK gene. It belongs to a class of drugs known as tyrosine kinase inhibitors, which work by targeting specific proteins involved in cancer cell growth. Alunbrig is typically associated with cases where the cancer has spread or is advanced. Its use is often considered when other treatments have not been effective or are not suitable.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Alunbrig
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.